285 related articles for article (PubMed ID: 23952187)
1. The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities.
Saloner B; Fullerton C; McGuire T
J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):401-9. PubMed ID: 23952187
[TBL] [Abstract][Full Text] [Related]
2. Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.
Walls M; Allen CG; Cabral H; Kazis LE; Bair-Merritt M
Acad Pediatr; 2018 Apr; 18(3):256-265. PubMed ID: 29061327
[TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade.
Morgan PL; Staff J; Hillemeier MM; Farkas G; Maczuga S
Pediatrics; 2013 Jul; 132(1):85-93. PubMed ID: 23796743
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic disparities in ADHD diagnosis by kindergarten entry.
Morgan PL; Hillemeier MM; Farkas G; Maczuga S
J Child Psychol Psychiatry; 2014 Aug; 55(8):905-13. PubMed ID: 24456307
[TBL] [Abstract][Full Text] [Related]
5. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
Barner JC; Khoza S; Oladapo A
Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
[TBL] [Abstract][Full Text] [Related]
6. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Palli SR; Kamble PS; Chen H; Aparasu RR
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
[TBL] [Abstract][Full Text] [Related]
7. Racial-Ethnic Differences in Patterns of Discontinuous Medication Treatment Among Medicaid-Insured Youths With ADHD.
Ji X; Druss BG; Lally C; Cummings JR
Psychiatr Serv; 2018 Mar; 69(3):322-331. PubMed ID: 29191137
[TBL] [Abstract][Full Text] [Related]
8. Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort.
Shi Y; Hunter Guevara LR; Dykhoff HJ; Sangaralingham LR; Phelan S; Zaccariello MJ; Warner DO
JAMA Netw Open; 2021 Mar; 4(3):e210321. PubMed ID: 33646315
[TBL] [Abstract][Full Text] [Related]
9. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
[TBL] [Abstract][Full Text] [Related]
11. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
Lawson KA; Johnsrud M; Hodgkins P; Sasané R; Crismon ML
Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786
[TBL] [Abstract][Full Text] [Related]
12. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
[TBL] [Abstract][Full Text] [Related]
13. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults.
Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu E; Erder MH
J Med Econ; 2013 Oct; 16(10):1203-15. PubMed ID: 23937642
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
15. Ethnic Disparities in School-Based Behavioral Health Service Use for Children With Psychiatric Disorders.
Locke J; Kang-Yi CD; Pellecchia M; Marcus S; Hadley T; Mandell DS
J Sch Health; 2017 Jan; 87(1):47-54. PubMed ID: 27917490
[TBL] [Abstract][Full Text] [Related]
16. Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications.
Ing C; Ma X; Sun M; Lu Y; Wall MM; Olfson M; Li G
Anesth Analg; 2020 Sep; 131(3):723-733. PubMed ID: 31923004
[TBL] [Abstract][Full Text] [Related]
17. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.
Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES
Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989
[TBL] [Abstract][Full Text] [Related]
18. Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.
Bali V; Kamble PS; Aparasu RR
J Manag Care Spec Pharm; 2015 Jun; 21(6):486-98. PubMed ID: 26011550
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
[TBL] [Abstract][Full Text] [Related]
20. Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
Setyawan J; Guérin A; Hodgkins P; Gauthier G; Cloutier M; Wu E; Erder MH
J Med Econ; 2013 Nov; 16(11):1275-89. PubMed ID: 24004347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
